Related Experiment Video
Updated: Mar 29, 2026

15:49
Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
2.0K
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions
Evguenia S Svarovskaia1, Edward Gane2, Hadas Dvory-Sobol1
1Gilead Sciences, Foster City, California.
The Journal of Infectious Diseases
|November 26, 2015
Summary
Sofosbuvir (SOF) can lead to NS5B variants L159F and V321A in some patients experiencing virologic failure. Adding ledipasvir (LDV) to SOF treatment significantly reduced the emergence of these resistance variants.
Area of Science:
- Hepatology and Virology
- Antiviral Drug Resistance
- Molecular Biology
Background:
- Sofosbuvir (SOF) is a key antiviral for Hepatitis C Virus (HCV) with a high barrier to resistance.
- Previous studies showed no S282T NS5B substitution or phenotypic resistance in phase 3 trials of SOF.
Purpose of the Study:
- To evaluate the emergence and potential association with resistance of NS5B variants L159F and V321A during SOF and ledipasvir/SOF (LDV/SOF) treatment.
- To assess the impact of these variants on retreatment outcomes.
Main Methods:
- Deep sequencing was employed to analyze NS5B variants in patients from 8 SOF studies and 5 LDV/SOF studies.
- Virologic failure and baseline samples were analyzed for the presence of L159F and V321A variants.
Main Results:
- NS5B variants L159F and V321A were detected in 15% and 5% of patients with virologic failure on SOF, respectively.
- Combination therapy with LDV/SOF reduced the emergence of these variants to 2% in patients with virologic failure.
- L159F and V321A did not impact retreatment outcomes with SOF, ribavirin, and pegylated interferon.
- Baseline L159F in genotype 1 patients was associated with increased virologic failure only in short-duration SOF/ribavirin regimens.
Conclusions:
- Deep sequencing confirmed NS5B variants L159F and V321A emerge in a subset of patients treated with SOF, but do not affect retreatment outcomes.
- Ledipasvir intensification with SOF significantly reduces the emergence of these resistance-associated variants.
- Baseline L159F in genotype 1 patients does not impact treatment outcomes with LDV/SOF.
Related Concept Videos
Hepatitis
37
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
37
Inhibitors of Viral Protein Synthesis
24
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
24
Viral Mutations
40.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.7K
Subviral Agents
748
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
748
Viruses with RNA Genomes
1.3K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.3K
Single Nucleotide Polymorphisms-SNPs
19.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K

